Supplementary Figure 1 from Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Authors :: Keizo Koya
James Barsoum
Yumiko Wada
Luisa Shin Ogawa
Jamie Acquaviva
Shuxia Ye
Jim Sang
Noriaki Tatsuta
Takayo Inoue
Dan Zhou
Ronald K. Blackman
David A. Proia
Kevin P. Foley
Lijun Sun
Zhenjian Du
Weiwen Ying
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 280K

Full Text Access

Tools